Literature DB >> 8008705

Diffusion and metabolism of prednisolone farnesylate in viable skin of the hairless mouse.

K Tojo1, K Yamada, T Hikima.   

Abstract

The diffusion and metabolism of prednisolone 21-farnesylate were investigated in viable skin of the hairless mouse in vitro. The prodrug ester was extensively metabolized in viable skin, while it was stable in the donor and receptor solutions. The rate of appearance of the prodrug and its metabolite prednisolone was markedly influenced by the direction of the skin placed between the in vitro diffusion half-cells. The rate of bioconversion of the prodrug was determined as a function of the distance from the surface of the skin. The prodrug was increasingly metabolized with the distance from the surface of the skin, indicating that the responsible enzymes are enriched in the lower layers of the viable skin. A model with linearly increasing enzyme activity in the viable skin accounts for the in vitro profiles of the diffusion/metabolism of the prodrug in the viable skin of hairless mouse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008705     DOI: 10.1023/a:1018960920313

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  2 in total

1.  Quantitative evaluation of ethanol effects on diffusion and metabolism of beta-estradiol in hairless mouse skin.

Authors:  P Liu; W I Higuchi; W Q Song; T Kurihara-Bergstrom; W R Good
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

2.  Drug permeation across the skin: effect of penetrant hydrophilicity.

Authors:  K Tojo; C C Chiang; Y W Chien
Journal:  J Pharm Sci       Date:  1987-02       Impact factor: 3.534

  2 in total
  2 in total

1.  Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin.

Authors:  K Sugibayashi; T Hayashi; T Hatanaka; M Ogihara; Y Morimoto
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

2.  Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway.

Authors:  Koji Yamaguchi; Tetsuya Mitsui; Toshinori Yamamoto; Rie Shiokawa; Yuko Nomiyama; Norihisa Ohishi; Yoshinori Aso; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2006-03-25       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.